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The  paper  by  Diao  et  al.,  published  in  the  present  issue  of  the  Archives  of  Cardiovascular
Diseases,  deserves  attention  because  original  data  on  the  contemporary  burden  of  heart
disease  in  sub-Saharan  Africa  are  scarce  [1].  This  paper  also  brings  a  reminder  of  the
maternal  risk  inherent  to  pregnancy  in  women  with  rheumatic  heart  disease.
The  distribution  of  heart  diseases  in  this  series  from  a  tertiary  African  centre  is  markedly
different  from  series  reporting  heart  disease  during  pregnancy  in  Western  countries.  In
series  from  Northern  America  or  Europe,  congenital  heart  disease  is  the  most  frequent
heart  disease  during  pregnancy,  followed  by  valvular  heart  disease  [2,3]. Most  cases  of
maternal  death  during  pregnancy  in  the  UK  registry  are  related  to  myocardial  disease,  pul-
monary  hypertension  and  myocardial  infarction,  death  related  to  valvular  disease  being
rare  and  mostly  due  to  infective  endocarditis  [4].  Conversely,  in  the  series  by  Diao  et  al.,
92%  of  women  hospitalized  because  of  heart  disease  during  pregnancy  in  a  University  Hospi-
tal  from  Senegal  presented  with  rheumatic  heart  valve  disease.  Rheumatic  mitral  stenosis
was  by  far  the  most  frequent  cause  of  heart  disease  during  pregnancy,  accounting  for  64%
of  all  cases.  These  striking  discrepancies  in  the  distribution  of  heart  disease  during  preg-
nancy  are  the  consequence  of  differences  in  the  epidemiology  of  heart  disease  between
Western  and  developing  countries.  The  emergence  of  congenital  heart  disease  as  the  lead-
ing  cause  of  heart  disease  during  pregnancy  in  Western  countries  is  the  consequence  of
decades  of  progress  in  the  detection  and  treatment  of  congenital  heart  disease,  which
is  not  the  case  in  developing  countries.  Although  heart  valve  disease  remains  prevalent
in  Western  countries,  there  has  been  a  shift  from  rheumatic  to  degenerative  aetiologies,
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hereby  explaining  a  dramatic  decrease  in  the  prevalence
f  severe  heart  valve  disease  in  young  women  [5].  Although
ccurate  statistics  are  lacking,  the  incidence  of  rheumatic
ever  is  estimated  at  13  cases  per  100,000  per  year  in
ub-Saharan  Africa  [6].  The  consequence  is  a  prevalence
stimated  between  2.7  and  14.3  per  1000  in  school-age
hildren  in  Africa  [7].  However,  it  should  be  stressed  that
uch  estimations  are  based  on  clinical  screening,  while
stimations  between  21.5  and  30.4  per  1000  have  been
eported  in  Cambodia  and  Mozambique  when  using  sys-
ematic  echocardiographic  screening  [8].  Besides  its  high
revalence,  rheumatic  heart  disease  in  developing  countries
s  characterized  by  the  occurrence  of  severe  heart  valve
isease  at  a  younger  age  than  in  Western  countries,  as  illus-
rated  by  series  of  percutaneous  mitral  commissurotomy  [9].
hus,  mitral  stenosis,  which  affects  women  more  frequently
han  men,  is  particularly  prevalent  in  women  of  childbearing
ge.
Besides  epidemiological  differences,  the  series  by  Diao
t  al.  also  highlights  the  considerable  risk  related  to  preg-
ancy  in  women  with  severe  symptomatic  mitral  stenosis.
lthough  women  were  hospitalized  in  a  tertiary  centre,  15
regnancy-related  deaths  occurred  among  the  32  women
ith  mitral  stenosis  and  the  presence  of  mitral  stenosis  was
 signiﬁcant  predictive  factor  of  maternal  mortality  in  this
eries.  These  ﬁgures  should  of  course  take  into  account  the
act  that  most  women  were  hospitalized  because  of  heart
ailure,  which  was  also  a  strong  predictive  factor  of  maternal
ortality  in  the  series  by  Diao  et  al.,  as  in  others.  The  toler-
nce  of  mitral  stenosis  is  particularly  poor  during  pregnancy
ecause  all  haemodynamic  changes  contribute  to  deteriora-
ion:  the  30  to  50%  increase  in  cardiac  output  determines  a
harp  increase  in  mitral  gradient,  which  is  further  enhanced
y  the  shortening  of  diastole  due  to  tachycardia  [4].  Even
n  women  who  were  asymptomatic  before  pregnancy,  most
evelop  dyspnoea  during  pregnancy  and  the  majority  of
hose  with  mitral  valve  area  <  1.5  cm2 develop  New  York
eart  Association  class  III  or  IV  dyspnoea  [10]. Haemody-
amic  decompensation  of  mitral  stenosis  during  pregnancy
xposes  patients  to  a  particularly  poor  prognosis  during  the
eripartum  period  because  of  the  superimposed  haemody-
amic  stress  related  to  delivery.  This  is  clearly  shown  in
he  paper  by  Dao  et  al.,  in  which  the  mortality  of  pregnant
omen  with  decompensated  mitral  stenosis  was  more  than
0%.
It is  important  to  draw  attention  to  the  frequency  and
isks  of  pregnancy-related  haemodynamic  decompensation
n  women  with  mitral  stenosis  in  developing  countries,
hich  contrasts  with  recent  series  from  Western  countries
eporting  maternal  mortality  rates  below  3%  [10—12]. These
ifferences  may  be  due  to  a  diagnosis  at  an  earlier  stage  and
o  the  use  of  therapeutic  resources  before  the  occurrence  of
omplications,  as  recommended  in  guidelines  [13]. In  partic-
lar,  early  diagnosis  enables  beta-blockers  to  be  prescribed,
ith  a  striking  efﬁcacy  on  mitral  gradient  and  pulmonary
rtery  pressures.  However,  when  symptoms  and/or  pul-
onary  hypertension  persist  despite  use  of  beta-blockers,
ossibly  combined  with  diuretics,  percutaneous  mitral  com-
issurotomy  should  be  considered  before  delivery  [13,14].
nfortunately,  percutaneous  mitral  commissurotomy  was
ot  available  in  the  centre  used  in  the  study  by  Diao
t  al.  because  of  its  cost  and  requirements,  in  particularB.  Iung
xperienced  interventional  cardiologists.  This  explains  why
losed-heart  commissurotomy  is  still  used  during  pregnancy
s  an  alternative  to  percutaneous  mitral  commissurotomy  in
eveloping  countries  for  economic  reasons  [15].
Another  feature  of  interest  is  the  fact  that  most  cardiac
eaths  occurred  during  the  postpartum  period.  It  is  well
nown  that  cardiac  output  remains  increased  during  the  days
ollowing  delivery  and  blood  shifting  from  the  placenta  fur-
her  increases  preload  [4].  This  underlines  the  need  for  a
lose  follow-up  during  the  days  following  delivery  in  patients
ith  known  heart  disease.
Finally,  the  paper  from  Diao  et  al.  presents  more  than
n  original  contribution  about  the  contemporary  presen-
ation  and  prognosis  of  heart  disease  during  pregnancy  in
ub-Saharan  Africa.  Beyond  the  speciﬁc  issues  related  to
regnancy,  this  work  draws  attention  to  the  consequences
f  the  persisting  high  burden  of  rheumatic  heart  disease
n  developing  countries.  This  should  be  an  incentive  to
ncourage  the  collection  of  data  on  the  presentation  and
anagement  of  heart  valve  disease  in  Africa.  Of  course,
conomic  considerations  remain  the  main  factor  limiting
he  improvement  in  the  prevention  of  rheumatic  fever
s  well  as  the  early  diagnosis  of  heart  valve  disease  to
llow  for  timely  intervention.  However,  data  collection  from
frica  may  contribute  to  drawing  attention  to  the  impact  of
heumatic  heart  disease,  which  is  largely  a  preventable  and
urable  disease.  This  paper  should  also  draw  to  the  atten-
ion  of  cardiologists  from  Western  countries  the  need  to
emain  aware  of  the  possibility  of  rheumatic  mitral  stenosis,
hich  remains  prevalent  in  Europe  in  migrant  populations,
lthough  rheumatic  fever  has  nearly  disappeared  in  Western
ountries.  This  is  of  particular  importance  during  preg-
ancy  given  the  impact  of  mitral  stenosis  and  the  possibility
f  using  medical  and  interventional  resources  to  improve
aternal  and  foetal  prognosis.
isclosure of interest
onsultancy:  Servier,  Boehringer  Ingelheim,  Bayer,  Abbott
nd  Valtech.
Speaker’s  fee:  Edwards  Lifesciences,  Saint-Jude  Medical,
nd  Sanoﬁ-Aventis.
eferences
[1] Diao M, Kane A, Ndiaye MB, et al. Pregnancy in women
with heart disease in sub-Saharan Africa. Cardiovasc Dis
2011;104:370—4.
[2] Siu SC, Sermer M, Colman JM, et al. Prospective multicenter
study of pregnancy outcomes in women with heart disease.
Circulation 2001;104:515—21.
[3] Stangl V, Schad J, Gossing G, Borges A, Baumann G, Stangl K.
Maternal heart disease and pregnancy outcome: a single-centre
experience. Eur J Heart Fail 2008;10:855—60.
[4] Thorne SA. Pregnancy in heart disease. Heart 2004;90:450—6.
[5] Iung B, Vahanian A. Epidemiology of valvular heart disease inthe adult. Nat Rev Cardiol 2011;8:162—72.
[6] Carapetis JR, Steer AC, Mulholland EK, Weber M. The global
burden of group A streptococcal diseases. Lancet Infect Dis
2005;5:685—94.
plic
[
[
[Rheumatic  heart  disease  and  pregnancy-related  cardiac  com
[7] Essop MR, Nkomo VT. Rheumatic and nonrheumatic valvular
heart disease: epidemiology, management, and prevention in
Africa. Circulation 2005;112:3584—91.
[8] Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic
heart disease detected by echocardiographic screening. N Engl
J Med 2007;357:470—6.
[9] Marijon E, Iung B, Mocumbi AO, et al. What are the differences
in presentation of candidates for percutaneous mitral commis-
surotomy across the world and do they inﬂuence the results of
the procedure? Arch Cardiovasc Dis 2008;101:611—7.
[10] Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular
heart disease on maternal and fetal outcome of pregnancy. J
Am Coll Cardiol 2001;37:893—9.
[11] Silversides CK, Colman JM, Sermer M, Siu SC. Cardiac risk in
pregnant women with rheumatic mitral stenosis. Am J Cardiol
2003;91:1382—5.
[ations  369
12] Lesniak-Sobelga A, Tracz W,  KostKiewicz M, Podolec P, Pasow-
icz M. Clinical and echocardiographic assessment of pregnant
women with valvular heart diseases–maternal and fetal out-
come. Int J Cardiol 2004;94:15—23.
13] Oakley C, Child A, Iung B, Presbitero P, Tornos P.
Expert consensus document on management of cardiovas-
cular diseases during pregnancy. Eur Heart J 2003;24:
761—81.
14] Vahanian A, Baumgartner H, Bax J, et al. Guidelines
on the management of valvular heart disease: The Task
Force on the Management of Valvular Heart Disease of
the European Society of Cardiology. Eur Heart J 2007;28:
230—68.
15] Aggarwal N, Suri V, Goyal A, Malhotra S, Manoj R, Dhaliwal RS.
Closed mitral valvotomy in pregnancy and labor. Int J Gynaecol
Obstet 2005;88:118—21.
